Claudin-targeted drug development using anti-claudin monoclonal antibodies to treat hepatitis and cancer.

Hashimoto, Yosuke; Fukasawa, Masayoshi; Kuniyasu, Hiroki; Yagi, Kiyohito; Kondoh, Masuo

Hashimoto, Yosuke; Fukasawa, Masayoshi; Kuniyasu, Hiroki; Yagi, Kiyohito; Kondoh, Masuo.

Afiliación

Hashimoto Y; Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
Fukasawa M; Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan.
Kuniyasu H; Department of Molecular Pathology, Nara Medical University, Nara, Japan.
Yagi K; Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
Kondoh M; Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.

Ann N Y Acad Sci ; 1397(1): 5-16, 2017 06.

Article en En | MEDLINE | ID: mdl-28415141

Asunto(s)

Anticuerpos Monoclonales/uso terapéutico; Claudina-1/metabolismo; Claudina-4/metabolismo; Hepacivirus/efectos de los fármacos; Hepatitis C/tratamiento farmacológico; Neoplasias/tratamiento farmacológico; Animales; Claudina-1/inmunología; Claudina-4/inmunología; Epidermis/metabolismo; Hepacivirus/fisiología; Hepatitis C/virología; Humanos; Uniones Estrechas/metabolismo

Palabras clave

cancer; claudin; epidermal absorption; hepatitis C virus; monoclonal antibody

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hepatitis C / Hepacivirus / Claudina-1 / Claudina-4 / Anticuerpos Monoclonales / Neoplasias Idioma: En Revista: Ann N Y Acad Sci Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google